Fortitude Family Office’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$284 Sell
6
-30
-83% -$1.54K ﹤0.01% 2067
2026
Q1
$2.13K Buy
+36
New +$2.34K ﹤0.01% 1265
2025
Q4
– Sell
-20
Closed -$1.25K – 2072
2025
Q3
$1.25K Buy
20
+4
+25% +$278 ﹤0.01% 1461
2025
Q2
$1.28K Buy
+16
New +$1.34K ﹤0.01% 1392

Other funds holding PBH

Fortitude Family Office's PBH Position: Q2 2026 in Review

Fortitude Family Office reduced its Prestige Consumer Healthcare (PBH) stake by 83% in Q2 2026, selling an estimated $1.54K and leaving 6 shares worth $284. The position accounts for ﹤0.01% of the portfolio, ranked #2067.

Fortitude Family Office first reported a position in PBH in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.13K in Q1 2026. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Fortitude Family Office held 6 shares of Prestige Consumer Healthcare worth $284 as of Q2 2026.
  • Fortitude Family Office sold 30 Prestige Consumer Healthcare shares in Q2 2026, an estimated $1.54K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #2067 holding.
  • Fortitude Family Office first reported a position in Prestige Consumer Healthcare in Q2 2025 and has held it in 4 quarters since.
  • Fortitude Family Office's Prestige Consumer Healthcare position peaked at $2.13K in Q1 2026.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.